Beauty Health Co
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
SKIN$15.94-4.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except for share amounts)
| Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| BALANCE, December 31, 2023 | 122,899,002 | $12 | $541,281 | $(3,036) | $(478,867) | $59,390 |
| Net loss | — | — | — | — | (679) | (679) |
| Issuance of common stock pursuant to equity compensation plan | 843,950 | — | — | — | — | — |
| Shares withheld for tax withholdings on vested stock awards | (289,533) | — | (1,005) | — | — | (1,005) |
| Share-based compensation | — | — | 6,636 | — | — | 6,636 |
| Foreign currency translation adjustments | — | — | — | (1,047) | — | (1,047) |
| BALANCE, March 31, 2024 | 123,453,419 | $12 | $546,912 | $(4,083) | $(479,546) | $63,295 |
| Net income | — | — | — | — | 202 | 202 |
| Issuance of common stock pursuant to equity compensation plan | 454,362 | — | — | — | — | — |
| Shares withheld for tax withholdings on vested stock awards | (104,120) | — | (368) | — | — | (368) |
| Issuance of common stock relating to employee stock purchase plan | 190,124 | — | 378 | — | — | 378 |
| Share-based compensation | — | — | 6,498 | — | — | 6,498 |
| Foreign currency translation adjustments | — | — | — | (816) | — | (816) |
| BALANCE, June 30, 2024 | 123,993,785 | $12 | $553,420 | $(4,899) | $(479,344) | $69,189 |
| BALANCE, December 31, 2024 | 124,924,185 | $12 | $566,709 | $(6,953) | $(507,965) | $51,803 |
|---|---|---|---|---|---|---|
| Net loss | — | — | — | — | (10,096) | (10,096) |
| Issuance of common stock pursuant to equity compensation plan | 483,396 | — | — | — | — | — |
| Shares withheld for tax withholdings on vested stock awards | (161,295) | — | (250) | — | — | (250) |
| Share-based compensation | — | — | 3,476 | — | — | 3,476 |
| Foreign currency translation adjustments | — | — | — | 1,128 | — | 1,128 |
| BALANCE, March 31, 2025 | 125,246,286 | $13 | $569,935 | $(5,825) | $(518,061) | $46,062 |
| Net income | — | — | — | — | 19,712 | 19,712 |
| Issuance of common stock pursuant to equity compensation plan | 2,091,026 | — | — | — | — | — |
| Shares withheld for tax withholdings on vested stock awards | (572,750) | — | (708) | — | — | (708) |
| Share-based compensation | — | — | 5,308 | — | — | 5,308 |
| Foreign currency translation adjustments | — | — | — | 3,629 | — | 3,629 |
| BALANCE, June 30, 2025 | 126,764,562 | $13 | $574,535 | $(2,196) | $(498,349) | $74,003 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.